HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kaei Nasu Selected Research

thiazolyl blue

5/2010Synergistic anti-neoplastic effect of AG1478 in combination with cisplatin or paclitaxel on human endometrial and ovarian cancer cells.
1/2010PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells.
11/2008Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
5/2008Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
4/2008Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
3/2008K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
4/2006M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.
3/2006Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
2/2006A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
1/2006CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kaei Nasu Research Topics

Disease

36Neoplasms (Cancer)
03/2022 - 03/2002
29Endometriosis
06/2022 - 10/2004
19Endometrial Neoplasms (Endometrial Cancer)
03/2022 - 08/2002
17Cysts
12/2021 - 09/2004
13Ovarian Neoplasms (Ovarian Cancer)
01/2018 - 07/2005
7Carcinogenesis
01/2019 - 08/2002
6Fibrosis (Cirrhosis)
12/2019 - 10/2005
5Ovarian Epithelial Carcinoma
03/2014 - 08/2002
5Choriocarcinoma
10/2012 - 01/2008
5Pathologic Processes
08/2007 - 09/2003
4Neoplasm Metastasis (Metastasis)
07/2020 - 06/2009
4Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2018 - 06/2009
3Leiomyoma (Uterine Fibroids)
01/2021 - 02/2006
3Leukemia
11/2016 - 07/2007
3B-Cell Lymphoma (Lymphoma, B Cell)
11/2016 - 07/2007
3Vomiting
02/2016 - 11/2014
3Hypoxia (Hypoxemia)
01/2014 - 09/2004
3Cystadenoma
09/2003 - 08/2002
2Inflammation (Inflammations)
06/2022 - 07/2003
2Melanoma (Melanoma, Malignant)
01/2022 - 02/2010
2Small Cell Carcinoma
01/2019 - 03/2011
2Lymphatic Metastasis
05/2018 - 04/2012
2Infections
01/2018 - 01/2010
2Nausea
02/2016 - 11/2014
2Cicatrix (Scar)
05/2013 - 10/2005
2Carcinoma (Carcinomatosis)
01/2011 - 06/2009
2Bacterial Infections (Bacterial Infection)
01/2011 - 08/2006
2Myoma
02/2009 - 10/2004
2Wounds and Injuries (Trauma)
10/2005 - 06/2005
2Adenoid Cystic Carcinoma (Cylindroma)
06/2005 - 01/2005
2Leukocytosis (Pleocytosis)
11/2004 - 01/2002
2Necrosis
10/2002 - 02/2002

Drug/Important Bio-Agent (IBA)

11Histone Deacetylase InhibitorsIBA
01/2014 - 01/2006
10Proteins (Proteins, Gene)FDA Link
10/2012 - 08/2002
10thiazolyl blueIBA
05/2010 - 01/2006
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2022 - 09/2004
7MicroRNAs (MicroRNA)IBA
06/2022 - 03/2013
6Estrogens (Estrogen)FDA Link
03/2022 - 11/2005
5Paclitaxel (Taxol)FDA LinkGeneric
07/2020 - 06/2009
5CollagenIBA
01/2020 - 06/2005
5DNA (Deoxyribonucleic Acid)IBA
01/2019 - 06/2005
5Cisplatin (Platino)FDA LinkGeneric
02/2016 - 01/2010
5Histones (Histone)IBA
01/2014 - 01/2011
4Messenger RNA (mRNA)IBA
01/2017 - 09/2004
4bufalinIBA
01/2012 - 11/2005
4Bromodeoxyuridine (BrdU)IBA
07/2007 - 01/2005
3ChemokinesIBA
01/2020 - 10/2004
3Phosphotransferases (Kinase)IBA
07/2017 - 05/2009
3Histone Deacetylases (Histone Deacetylase)IBA
01/2014 - 01/2006
3Biological ProductsIBA
01/2012 - 09/2004
3SurvivinIBA
09/2004 - 08/2002
2Immune Checkpoint InhibitorsIBA
01/2021 - 07/2020
2PlatinumIBA
07/2020 - 03/2014
2Carboplatin (JM8)FDA LinkGeneric
07/2020 - 06/2009
2Cyclin D1IBA
07/2017 - 11/2016
2Aromatase InhibitorsIBA
10/2016 - 02/2009
2Dexamethasone (Maxidex)FDA LinkGeneric
02/2016 - 11/2014
2Palonosetron (Aloxi)FDA Link
02/2016 - 11/2014
2Aprepitant (Emend)FDA Link
02/2016 - 11/2014
2Hormones (Hormone)IBA
10/2014 - 07/2009
2Death Domain ReceptorsIBA
01/2014 - 12/2013
2Cadherins (E-Cadherin)IBA
01/2014 - 07/2011
2Homeobox A10 ProteinsIBA
01/2014 - 07/2011
2PK 11195 (PK11195)IBA
10/2012 - 01/2010
2Calmodulin (Calcium-Dependent Activator Protein)IBA
08/2012 - 05/2009
2CalciumIBA
08/2012 - 05/2009
2KN 93IBA
08/2012 - 05/2009
2Therapeutic UsesIBA
01/2012 - 01/2011
2Estrogen ReceptorsIBA
07/2011 - 03/2002
2Phospholipids (Phosphatides)FDA LinkGeneric
06/2011 - 11/2008
2erucylphosphocholineIBA
06/2011 - 11/2008
2LipidsIBA
06/2011 - 11/2008
2Ether (Diethyl Ether)IBA
06/2011 - 11/2008
2InterferonsIBA
01/2011 - 09/2004
2AlkaloidsIBA
03/2008 - 07/2005
2StaurosporineIBA
03/2008 - 07/2005
2staurosporine aglycone (K252a)IBA
03/2008 - 07/2005
2Pharmaceutical PreparationsIBA
01/2008 - 01/2006
2Protein Isoforms (Isoforms)IBA
10/2005 - 06/2005
2CytokinesIBA
01/2005 - 09/2003
2Interferon-gamma (Interferon, gamma)IBA
01/2005 - 02/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2003 - 02/2002
2Interleukin-1beta (Interleukin 1 beta)IBA
10/2002 - 02/2002
1Metalloproteases (Metalloproteinases)IBA
06/2022
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2022
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2022
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
06/2022
1Phosphatidylinositols (Phosphatidylinositol)IBA
06/2022

Therapy/Procedure

19Therapeutics
06/2022 - 04/2008
13Aftercare (After-Treatment)
12/2019 - 01/2002
12Drug Therapy (Chemotherapy)
07/2020 - 06/2005
7Radiotherapy
07/2020 - 06/2005
7Hysterectomy
01/2019 - 10/2004
5Lymph Node Excision (Lymph Node Dissection)
01/2019 - 01/2005
3Laparotomy
01/2021 - 02/2006
3Adjuvant Chemotherapy
05/2018 - 05/2014
2Salpingo-oophorectomy
05/2014 - 02/2006
2Combined Modality Therapy
03/2011 - 06/2009
2Conservative Treatment
05/2010 - 08/2008
2Intrauterine Devices (Intrauterine Device)
05/2010 - 01/2002